MEGAN SCHLEIGH: Open Payments
NPI 1437775244 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 48 payments from 11 companies in 2025. Trend: 2023 $3,238 · 2024 $2,673 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $157 |
| ABBVIE INC. | 5 | $88 |
| Janssen Biotech, Inc. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Lilly USA, LLC | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 7 | $42 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $27 |
Products named: XELJANZ, VELSIPITY, TREMFYA, XIFAXAN, RINVOQ, OMVOH, VOQUEZNA, ZENPEP.
Industry payments across TN — which companies pay providers there.
